Patent · US Active

Formulations of ladostigil tartrate

US8022104B2 · kind B2 · utility

0Cited by
8References
11Claims
0Family size

Assignees

Inventors

Key dates

Filing dateFeb 24, 2006
Grant dateSep 20, 2011
Priority date
Expiry dateAug 20, 2027

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are formulations of ladostigil tartrate, including pharmaceutical compositions, process for the manufacture, and use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.